Below are the most recent publications written about "Colorectal Neoplasms" by people in Profiles.
						
					
								- 
								
de Carvalho AC, Laus AC, Lopes Junior HR, Porto J, Sant'Anna Silva D, Ribeiro AG, Datorre JG, Tavares RM, Sousa Carlos AB, Furquim T, Uno M, Chammas R, Villela P, Dos Reis MB, de Medeiros Matsushita M, Oliveira MA, Hirai WY, Guimar?es DP, Santos FA, Reis RM. Association of Genetic Ancestry and Colorectal Cancer Risk in a Large Brazilian Cohort: Replication of Single-Nucleotide Polymorphisms Identified by Genome-Wide Association Studies. JCO Glob Oncol. 2025 Jun; 11:e2400512.
															
								 
							
								- 
								
Casta?eda-Avila MA, Latoni-Guillermety D, Sabatino M, Ortiz-Ortiz KJ, Lapane KL. Challenges oncologists face when caring for hispanics living in puerto rico with colorectal cancer and multiple chronic conditions. BMC Cancer. 2025 May 20; 25(1):898.
															
								 
							
								- 
								
Skelly DA, Graham JP, Cheng M, Furuta M, Walter A, Stoklasek TA, Yang H, Stearns TM, Poirion O, Zhang JG, Grassmann JDS, Luo D, Flynn WF, Courtois ET, Chang CH, Serreze DV, Menghi F, Reinholdt LG, Liu ET. Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response. Cell Rep. 2025 May 27; 44(5):115698.
															
								 
							
								- 
								
Pieters TA, Hersh AM, Elsamadicy AA, Pennington Z, Santangelo G, Najjar S, Hung B, Ber R, Atallah C, Efron J, Gearhart S, Safar B, Wolinsky JP, Sciubba DM, Lo SL. Outcomes after en bloc resection with sacrectomy of advanced colorectal carcinomas that invade the sacrum: a multiinstitutional descriptive series. J Neurosurg Spine. 2025 May 01; 42(5):598-604.
															
								 
							
								- 
								
Nieser KJ, Harris AHS, Binswanger IA, Clark SC, Finlay AK. Legal-involved veterans are less likely to receive guideline-concordant colorectal cancer screening. BMC Health Serv Res. 2025 Mar 04; 25(1):333.
															
								 
							
								- 
								
Chen JK, Merrick KA, Kong YW, Izrael-Tomasevic A, Eng G, Handly ED, Patterson JC, Cannell IG, Suarez-Lopez L, Hosios AM, Dinh A, Kirkpatrick DS, Yu K, Rose CM, Hernandez JM, Hwangbo H, Palmer AC, Vander Heiden MG, Yilmaz ?H, Yaffe MB. An RNA damage response network mediates the lethality of 5-FU in colorectal cancer. Cell Rep Med. 2024 Oct 15; 5(10):101778.
															
								 
							
								- 
								
Krugliak Cleveland N, Ghosh S, Chastek B, Bancroft T, Candela N, Fan T, Umashankar K, Rubin DT. Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314.
															
								 
							
								- 
								
Casta?eda-Avila MA, Tisminetzky M, Oyinbo AG, Lapane K. Racial and Ethnic Disparities in Use of Colorectal Cancer Screening Among Adults With Chronic Medical Conditions: BRFSS 2012-2020. Prev Chronic Dis. 2024 Feb 22; 21:E12.
															
								 
							
								- 
								
Valentino JD, Garcia OR, Tyler KM. What Every Colorectal Surgeon Needs to Know about the Proposed Limitations to Noncompete Clauses. Dis Colon Rectum. 2024 May 01; 67(5):606-608.
															
								 
							
								- 
								
Zhou B, Kwan B, Desai MJ, Nalawade V, Henk J, Viravalli N, Murphy JD, Nathan PC, Ruddy KJ, Shliakhtsitsava K, Su HI, Whitcomb BW. Association of platinum-based chemotherapy with live birth and infertility in female survivors of adolescent and young adult cancer. Fertil Steril. 2024 Jun; 121(6):1020-1030.